graft versus host disease

Kadmon preps filing for GVHD drug belumosudil after phase 3 win

https://pharmaphorum.com/news/kadmon-preps-filing-for-gvhd-drug-belumosudil-after-phase-3-win/

Kiadis sheds half its staff as lead cell therapy bombs

https://pharmaphorum.com/news/kiadis-sheds-half-its-staff-as-lead-cell-therapy-bombs/

Janssen/AbbVie drug approved in graft-versus-host disease

https://pharmaphorum.com/news/imbruvica-drug-approved-graft-versus-host-disease/

Imbruvica granted fourth Breakthrough status

https://pharmaphorum.com/news/abbvies-imbruvica-granted-breakthrough-therapy-designation-cgvhd/

Close in 10 seconds

Pharmaphorum.com

Search